• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RETRACTION: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.撤稿声明:丹参酮I通过使PI3K/AKT/mTOR通路失活诱导细胞凋亡和自噬,从而减弱卵巢癌的恶性生物学特性。
Cell Prolif. 2025 Feb;58(2):e13768. doi: 10.1111/cpr.13768. Epub 2024 Oct 23.
2
RETRACTION: Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.撤回声明:葛根素6″-O-木糖苷通过抑制PI3K/AKT/mTOR调节增殖、干性和凋亡来抑制肝癌。
Cancer Med. 2024 Oct;13(19):e70301. doi: 10.1002/cam4.70301.
3
RETRACTION: MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.撤稿声明:MATN1-AS1作为miR-200b/c/429的竞争性内源RNA发挥作用,通过调节CHD1表达促进胶质瘤进展。
Cell Prolif. 2024 Dec;57(12):e13767. doi: 10.1111/cpr.13767. Epub 2024 Oct 20.
4
RETRACTION: Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.撤稿声明:长链非编码RNA CASC9通过海绵吸附miR-488-3p促进甲状腺乳头状癌的增殖和转移。
Cancer Med. 2024 Oct;13(19):e70302. doi: 10.1002/cam4.70302.
5
RETRACTION: GANT61 Plays Antitumor Effects by Inducing Oxidative Stress through the miRNA-1286/RAB31 Axis in Osteosarcoma.撤回声明:GANT61通过miRNA-1286/RAB31轴诱导氧化应激在骨肉瘤中发挥抗肿瘤作用。
Cell Biol Int. 2025 Feb;49(2):201. doi: 10.1002/cbin.12271. Epub 2025 Jan 1.
6
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.撤稿声明:丁,J.,王,X.,高,J. 和宋,T.(2021年),胱抑素SN沉默可消除甲状腺乳头状癌的癌症进展和干细胞特性。《欧洲生物化学学会联合会开放生物学》,11: 2186 - 2197。
FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
7
RETRACTION: Rotenone Restrains the Proliferation, Motility and Epithelial-Mesenchymal Transition of Colon Cancer Cells and the Tumourigenesis in Nude Mice via PI3K/AKT Pathway.撤稿声明:鱼藤酮通过PI3K/AKT通路抑制结肠癌细胞的增殖、迁移和上皮-间质转化以及裸鼠肿瘤发生。
Clin Exp Pharmacol Physiol. 2025 Feb;52(2):e70014. doi: 10.1111/1440-1681.70014.
8
RETRACTION: PEG2000-DPSE-Coated Quercetin Nanoparticles Remarkably Enhanced Anticancer Effects through Induced Programed Cell Death on C6 Glioma Cells.撤稿声明:聚乙二醇2000-二棕榈酰磷脂酰乙醇胺包被的槲皮素纳米颗粒通过诱导C6胶质瘤细胞程序性死亡显著增强抗癌效果。
J Biomed Mater Res A. 2025 May;113(5):e37894. doi: 10.1002/jbm.a.37894.
9
RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.撤回声明:MCCK1增强替莫唑胺在体外和体内减弱胶质母细胞瘤细胞侵袭、迁移及上皮-间质转化方面的抗癌作用。
Cancer Med. 2024 Oct;13(19):e70300. doi: 10.1002/cam4.70300.
10
RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.撤回声明:微小RNA-16通过抑制BCL2以及核因子-κB1/基质金属蛋白酶-9信号通路来抑制胶质瘤细胞的生长和侵袭。
Cancer Sci. 2024 Sep;115(9):3200. doi: 10.1111/cas.16269. Epub 2024 Jul 22.

本文引用的文献

1
Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.丹参酮 I 通过抑制 PI3K/AKT/mTOR 通路诱导细胞凋亡和自噬来抑制卵巢癌细胞的恶性生物学特性。
Cell Prolif. 2020 Feb;53(2):e12739. doi: 10.1111/cpr.12739. Epub 2019 Dec 9.

撤稿声明:丹参酮I通过使PI3K/AKT/mTOR通路失活诱导细胞凋亡和自噬,从而减弱卵巢癌的恶性生物学特性。

RETRACTION: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.

出版信息

Cell Prolif. 2025 Feb;58(2):e13768. doi: 10.1111/cpr.13768. Epub 2024 Oct 23.

DOI:10.1111/cpr.13768
PMID:39443824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11839184/
Abstract

J. Zhou , Y.-y. Jiang , H. Chen , Y.-c. Wu , and L. Zhang , "Tanshinone I Attenuates the Malignant Biological Properties of Ovarian Cancer by Inducing Apoptosis and Autophagy via the Inactivation of PI3K/AKT/mTOR Pathway," Cell Proliferation 53, no. 2 (2020): e12739. https://doi.org/10.1111/cpr.12739. The above article, published online on 09 December 2019, in Wiley Online Library (wileyonlinelibrary.com), and has been retracted by agreement between the journal Deputy Editor, Yunfeng Lin; and John Wiley & Sons Ltd. A third party contacted the publisher to report that duplicated images had been detected in multiple different articles by different author groups, each of which described different experimental conditions. The image duplications are listed as follows: Images in Figure 1C were duplicated in Wang et al. 2019 (https://doi.org/10.2147/OTT.S221161), which was submitted and published prior to the publication of this article in Cell Proliferation. In addition, duplicate images from Figures 1C, 1D, 2C, 3B, 3D, 4C, 4D, and 5D were detected in many other articles by different author groups that had been published subsequent to this article. The authors responded to an inquiry by the publisher regarding these concerns and shared what were labeled as original images for Figures 1-6 but did not share the original images for the cell proliferation assays that had been used in Figure 1. The editors reviewed this evidence and found that it did not properly explain the duplications across different articles. The retraction has been agreed to because the duplications of images across different articles fundamentally compromises the conclusions and results presented in the article. The authors disagree with the retraction.

摘要

周J、姜Y - y、陈H、吴Y - c和张L,“丹参酮I通过PI3K/AKT/mTOR通路失活诱导凋亡和自噬来减弱卵巢癌的恶性生物学特性”,《细胞增殖》第53卷,第2期(2020年):e12739。https://doi.org/10.1111/cpr.12739 。上述文章于2019年12月9日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据期刊副主编林云峰与约翰·威利父子有限公司的协议撤回。第三方联系出版商报告称,在不同作者团队的多篇不同文章中检测到重复图像,每篇文章描述的实验条件不同。图像重复情况如下:图1C中的图像在Wang等人2019年的文章(https://doi.org/10.2147/OTT.S221161)中重复出现,该文章在本文发表于《细胞增殖》之前已提交并发表。此外,在本文发表之后发表的许多其他不同作者团队的文章中也检测到图1C、1D、2C、3B、3D、4C、4D和5D的重复图像。作者回复了出版商关于这些问题的询问,并分享了标记为图1 - 6的原始图像,但未分享图1中细胞增殖实验所使用的原始图像。编辑审查了这些证据,发现其未能恰当解释不同文章中的重复情况。之所以同意撤回,是因为不同文章间图像的重复从根本上损害了文章中呈现的结论和结果。作者不同意撤回。